Pulmonx Corporation
General ticker "LUNG" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $78.0M (TTM average)
Pulmonx Corporation follows the US Stock Market performance with the rate: 16.6%.
Estimated limits based on current volatility of 4.1%: low 2.28$, high 2.48$
Factors to consider:
- Total employees count: 296 (+1.7%) as of 2025
- US accounted for 67.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Single product reliance, Manufacturing capacity limits, Regulatory and compliance, Cybersecurity threats, Litigation risks
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.37$, 4.33$]
- 2026-12-31 to 2027-12-31 estimated range: [1.60$, 4.78$]
Financial Metrics affecting the LUNG estimates:
- Positive: with PPE of -1.7 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -35.21 <= 0.28
- Positive: Inventory ratio change, % of -1.80 <= -0.75
- Positive: 18.97 < Shareholder equity ratio, % of 41.86 <= 42.26
- Positive: Investing cash flow per share per price, % of 33.15 > -0.64
Short-term LUNG quotes
Long-term LUNG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $68.67MM | $83.79MM | $90.50MM |
| Operating Expenses | $130.61MM | $141.49MM | $144.16MM |
| Operating Income | $-61.94MM | $-57.70MM | $-53.66MM |
| Non-Operating Income | $1.66MM | $1.81MM | $0.29MM |
| Interest Expense | $3.23MM | $3.51MM | $3.15MM |
| R&D Expense | $18.08MM | $17.57MM | $19.49MM |
| Income(Loss) | $-60.27MM | $-55.89MM | $-53.38MM |
| Taxes | $0.57MM | $0.50MM | $0.63MM |
| Net Income(Loss)* | $-60.84MM | $-56.39MM | $-54.00MM |
| Stockholders Equity | $118.31MM | $85.81MM | $54.12MM |
| Inventory | $16.74MM | $16.91MM | $15.85MM |
| Assets | $177.78MM | $162.85MM | $129.29MM |
| Operating Cash Flow | $-37.61MM | $-31.54MM | $-32.38MM |
| Capital expenditure | $0.81MM | $1.45MM | $0.45MM |
| Investing Cash Flow | $-2.01MM | $17.48MM | $30.48MM |
| Financing Cash Flow | $21.40MM | $1.36MM | $0.83MM |
| Earnings Per Share** | $-1.60 | $-1.44 | $-1.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.